The Indian patent controller's draft 'Guidelines for Examination of Patent Applications in the field of Pharmaceuticals', issued in April this year, has evoked tremendous response both within and outside the country as a large number of national and international pharma associations, experts and patent law firms have submitted their suggestions and comments to the patent office.
After examining these suggestions and comments, the Indian patent controller will incorporate the relevant suggestions before finally issuing the final document on 'Guidelines for Examination of Patent Applications in the field of Pharmaceuticals'.
Earlier in April this year, the Indian Controller General of Patents, Designs and Trade Marks had issued the draft 'Guidelines for Examination of Patent Applications in the field of Pharmaceuticals' to help the Examiners and the Controllers of the Patent Office in achieving consistently uniform standards of patent examination and grant of patents.
These guidelines are supplemental to the practices and procedures followed by the Patent Office as published in the ‘Manual of Patent Office Practice and Procedure’, “Guidelines For Examination of Biotechnology Applications” and the “Guidelines For Processing of Patent Applications Relating to Traditional Knowledge and Biological Material”.
The major pharmaceutical associations which had submitted their comments included Pharmaceutical Research and Manufacturers of America (PhRMA); European Commission, Directorate-General for Trade; European Federation of Pharmaceutical Industries and Associations (EFPIA); International Federation of Pharmaceutical Manufacturers and Associations (IFPMA); Japan Intellectual Property Association (JIPA); Japan Pharmaceutical Manufacturers Association (JPMA); Assocham; Biotechnology Industry Organization (BIO); Organisation of Pharmaceutical Producers of India (OPPI); FICPI; US-India Business Council (USIBC); etc.
http://www.pharmabiz.com/NewsDetails.aspx?aid=82431&sid=1
After examining these suggestions and comments, the Indian patent controller will incorporate the relevant suggestions before finally issuing the final document on 'Guidelines for Examination of Patent Applications in the field of Pharmaceuticals'.
Earlier in April this year, the Indian Controller General of Patents, Designs and Trade Marks had issued the draft 'Guidelines for Examination of Patent Applications in the field of Pharmaceuticals' to help the Examiners and the Controllers of the Patent Office in achieving consistently uniform standards of patent examination and grant of patents.
These guidelines are supplemental to the practices and procedures followed by the Patent Office as published in the ‘Manual of Patent Office Practice and Procedure’, “Guidelines For Examination of Biotechnology Applications” and the “Guidelines For Processing of Patent Applications Relating to Traditional Knowledge and Biological Material”.
The major pharmaceutical associations which had submitted their comments included Pharmaceutical Research and Manufacturers of America (PhRMA); European Commission, Directorate-General for Trade; European Federation of Pharmaceutical Industries and Associations (EFPIA); International Federation of Pharmaceutical Manufacturers and Associations (IFPMA); Japan Intellectual Property Association (JIPA); Japan Pharmaceutical Manufacturers Association (JPMA); Assocham; Biotechnology Industry Organization (BIO); Organisation of Pharmaceutical Producers of India (OPPI); FICPI; US-India Business Council (USIBC); etc.
http://www.pharmabiz.com/NewsDetails.aspx?aid=82431&sid=1
No comments:
Post a Comment